Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Ionis Pharmaceuticals Inc | 563 |
| 2 | F Hoffmann La Roche AG | 342 |
| 3 | Abbott Laboratories | 328 |
| 4 | Novartis AG | 287 |
| 5 | Bayer Pharma AG | 257 |
| 6 | Auspex Pharmaceuticals Inc | 240 |
| 7 | Evonik Operations GmbH | 225 |
| 8 | Janssen Pharmaceutica NV | 218 |
| 9 | Bayer Intellectual Property GmbH | 208 |
| 10 | EIDP Inc | 163 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 13,240 |
| 2 | A61K | Medicinal preparations | 10,949 |
| 3 | C12N | Microorganisms, enzymes | 8,910 |
| 4 | C07D | Heterocyclic compounds | 7,852 |
| 5 | C07K | Peptides | 4,751 |
| 6 | G01N | Investigating / analysing materials | 4,642 |
| 7 | C12P | Fermentation, enzyme processes | 4,405 |
| 8 | C12Y | Enzyme nomenclature (EC numbers) | 3,121 |
| 9 | C12Q | Measuring/testing involving enzymes | 2,787 |
| 10 | C07C | Acyclic and carbocyclic compounds | 1,536 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Polymorphisms in the glucose-6 phosphate dehydrogenase locus | 1999 | Affymetrix Inc | 122 |
| Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases | 2000 | Siemens Healthcare Diagnostics Products GmbH | 63 |
| Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases | 2002 | Danisco US Inc | 53 |
| Method for stabilizing glucose 6-phosphate dehydrogenase with hydroxylamines, aldehyde scavengers, dimethylthiocarbamoyl chloride or 2-(2-aminoethylamino) ethanol | 1995 | Minaris Medical Co Ltd | 49 |
| Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases | 2000 | Siemens Healthcare Diagnostics GmbH Germany | 41 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Pancreatic function and diabetes | 14 |
| 2 | Glycogen Storage Diseases and Myoclonus | 7 |
| 3 | Cancer, Hypoxia, and Metabolism | 5 |
| 4 | Carbohydrate Chemistry and Synthesis | 4 |
| 5 | Erythrocyte Function and Pathophysiology | 4 |
| 6 | Mitochondrial Function and Pathology | 4 |
| 7 | Plant nutrient uptake and metabolism | 4 |
| 8 | Advanced Glycation End Products research | 3 |
| 9 | Enzyme Structure and Function | 3 |
| 10 | Fungal and yeast genetics research | 3 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Joan J. Guinovart | Universitat de Barcelona | 19 |
| 2 | Rivka Beitner | Bar-Ilan University | 18 |
| 3 | Abdullah Sener | Université Libre de Bruxelles | 17 |
| 4 | Angelo Benedetti | University of Siena | 14 |
| 5 | Ann N. Burchell | Ninewells Hospital | 13 |
| 6 | Janice Y. Chou | National Institutes of Health | 11 |
| 7 | Abram Katz | Karolinska Institutet | 11 |
| 8 | Josep Carreras | Universitat de Barcelona | 10 |
| 9 | Gerald I. Shulman | Yale University | 9 |
| 10 | A.R. Ferré-D′Amaré | National Heart Lung and Blood Institute | 8 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| New insights on trehalose: a multifunctional molecule | 2003 | 1964 | Fungal and yeast genetics research |
| Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity | 1999 | 1313 | Metabolism, Diabetes, and Cancer |
| Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. | 2002 | 1199 | Genomics, phytochemicals, and oxidative stress |
| Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function | 2003 | 1107 | Pancreatic function and diabetes |
| Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions | 2001 | 1101 | Lung Cancer Diagnosis and Treatment |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Glucose 6-phosphate?
Which organizations have filed the most patents related to Glucose 6-phosphate?
What research topics are most associated with Glucose 6-phosphate in the scientific literature?
Who are the most prolific authors publishing on Glucose 6-phosphate research?
What patent classifications are most frequently associated with Glucose 6-phosphate inventions?